Cancer drug Xeloda linked to severe skin reactions, official reports

December 5, 2013

A drug used to treat advanced breast and colorectal cancers has been linked to sometimes fatal skin reactions in patients, its Swiss manufacturer and Canadian health officials said Wednesday.

Xeloda, which treats advanced cancer after complete surgical removal, can cause "severe skin reactions," Health Canada said in a statement.

It said patients had reported severe , such as the life-threatening known as Stevens-Johnson Syndrome or toxic epidermal necrolysis.

The signs and symptoms of this hypersensitivity include flu-like symptoms, fever, itchy skin, mouth sores, as well as painful, red or purplish skin rash that spreads and blisters, causing the top of the skin to shed, along with eye burning, itching and discharge.

Health Canada urged patients using Xeloda to contact their physician "immediately" after experiencing any of those signs or symptoms, so that they may report these to Roche or Health Canada.

Following requests from Canadian health authorities, Hoffmann-La Roche said it will be working with Health Canada to update the drug's prescribing information document.

It has sent a letter to healthcare professionals warning of the "risk of severe cutaneous reactions associated with the use of Xeloda," though it stressed that those cases were "very rare."

Explore further: FDA warns of rare skin reactions to acetaminophen

Related Stories

FDA warns of rare skin reactions to acetaminophen

August 2, 2013
(HealthDay)—The widely used painkiller acetaminophen, best known as Tylenol, can cause rare but serious skin reactions and a warning about this danger will be added to product labels, the U.S. Food and Drug Administration ...

Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

November 1, 2012
(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University of Otago, Wellington ...

Temporary tattoos may leave permanent damage

March 26, 2013
(HealthDay)—As thousands of college students head to sunny spots for spring break, getting temporary tattoos may seem like a fun thing to do. But the U.S. Food and Drug Administration warns that they can cause blisters ...

At least 23 Canadian deaths linked to contraceptive

June 11, 2013
At least 23 Canadian women died and hundreds more may have been harmed taking the world's two most commonly prescribed birth control pills, the country's public broadcaster said Tuesday.

EU regulator: No more problems with Roche drugs

November 19, 2013
The European Medicines Agency says it has finished an investigation of the way pharmaceutical giant Roche reported side effects for 19 drugs in the U.S. and has found no new safety concerns.

AAD: Skin changes can be first sign of underlying condition

March 1, 2013
(HealthDay)—Skin changes, including new rash, new growths, discoloration, and changes in texture, could be among the first signs indicating an underlying medical condition, according to information presented at the annual ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.